RPL4P2

Across TCGA pan-cancer cohorts, RPL4P2 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPL4P2 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RPL4P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL4P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

SKCM, LIHC, and LUAD are the cancer types where RPL4P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.719	0.544	.001	59	view →
LIHC	OS	Median	All	0.467	0.644	.001	25	view →
LUAD	DFS	Tertile	IV	0.787	0.278	.014	18	view →
BRCA	DFS	Median	III,IV	0.925	0.828	.002	17	view →
OV	OS	Median	III,IV	0.640	0.721	.010	14	view →
LGG	OS	Quartile	All	0.958	0.841	.001	12	view →
COAD	OS	Quartile	All	0.917	0.819	.012	11	view →
PAAD	DFS	Quartile	All	0.316	0.474	.030	10	view →
CESC	DFS	Quartile	All	0.699	0.464	.012	10	view →
ACC	OS	Quartile	All	0.502	1.000	.014	10	view →
THCA	DFS	Median	All	0.879	0.774	.013	6	view →
CHOL	OS	Median	II,III,IV	0.803	0.391	.030	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RPL4P2–SKCM (DFS)

Open the SKCM breakdown →